Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Israel / NCT06932679
Recruiting Observational

Perception of Affordances and Obstacle Crossing in People With Parkinson's Disease and Healthy Adults

NCT06932679 · tracked via the Priya Life Science Israel tracker
Phase
Observational
Started
2025-04-24
Last updated
2025-07-22

Condition(s) studied

Parkinson's Disease (PD)

Investigational drug(s) / intervention(s)

Assessment of Gait and Visual Exploration

Assessment of Gait and Visual Exploration: Participants will perform walking tasks involving obstacle crossing while their gait and visual exploration patterns are recorded using wearable sensors and eye-tracking glasses. This is a non-invasive observational study with no therapeutic intervention.

Study summary

This study aims to explore how young adults, older adults and people with Parkinson's disease (PwP), perceive their abilty to cross obstacles while walking, and how this perception is related to their actual performance of obstacle crossing and disease-related motor and cognitive impairments. The study will explore this percepeption and the actual performance in different walking environments(floor, synthetic grass turf). Understanding how people perceive obstacles may help improve rehabilitation methods and reduce the risk of falls. The study will take place at the Motor Performance Laboratory, University of Haifa, and will include walking tasks, eye-tracking measurements, and motor and cognitive assessments.

Eligibility

Sex
ALL
Min age
20 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Participants aged 20 to 80 years. * Ability to walk independently outdoors without assistive devices. * For Parkinson's Disease (PD) group: Diagnosis of PD confirmed by medical records. * For healthy control groups: No neurological or orthopedic conditions affecting gait. Exclusion Criteria: * Feezing of gait (for PD group only), based on a score greater than 0 on the Freezing of Gait Questionnaire. * Severe visual impairment that cannot be corrected with glasses or lenses. * Cognitive impairment, defined as a score below 18 on the telephone-based Mini-Mental State Examination (MMSE). * Any orthopedic condition, pain, or other medical condition that may affect walking, based on self-report.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Haifa, Motor Performance Laboratory Haifa Israel Recruiting

More University of Haifa trials in Israel

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06932679 on ClinicalTrials.gov ↗ ← All trials in Israel